WO2007036491A1 - Method for the production of alpha-substituted carboxylic acids - Google Patents
Method for the production of alpha-substituted carboxylic acids Download PDFInfo
- Publication number
- WO2007036491A1 WO2007036491A1 PCT/EP2006/066641 EP2006066641W WO2007036491A1 WO 2007036491 A1 WO2007036491 A1 WO 2007036491A1 EP 2006066641 W EP2006066641 W EP 2006066641W WO 2007036491 A1 WO2007036491 A1 WO 2007036491A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- carboxylic acid
- branched
- alkyl
- chlorine
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 41
- 150000001735 carboxylic acids Chemical class 0.000 title abstract description 15
- 238000004519 manufacturing process Methods 0.000 title abstract description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 28
- 150000001733 carboxylic acid esters Chemical class 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 150000001875 compounds Chemical class 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 19
- 239000000460 chlorine Substances 0.000 claims description 18
- 229910052801 chlorine Inorganic materials 0.000 claims description 18
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 15
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 13
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 13
- 229910052794 bromium Inorganic materials 0.000 claims description 13
- 125000004122 cyclic group Chemical group 0.000 claims description 12
- 229910052744 lithium Inorganic materials 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 9
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 7
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 239000008139 complexing agent Substances 0.000 claims description 6
- 125000005265 dialkylamine group Chemical group 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 150000007942 carboxylates Chemical class 0.000 claims description 5
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 5
- 125000004986 diarylamino group Chemical group 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 5
- 125000004001 thioalkyl group Chemical group 0.000 claims description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 4
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 239000006184 cosolvent Substances 0.000 claims description 3
- 238000001212 derivatisation Methods 0.000 claims description 3
- 230000032050 esterification Effects 0.000 claims description 3
- 238000005886 esterification reaction Methods 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 239000002841 Lewis acid Substances 0.000 claims description 2
- 150000007517 lewis acids Chemical class 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- 230000002152 alkylating effect Effects 0.000 abstract 1
- -1 allyl halides Chemical class 0.000 description 32
- 239000002585 base Substances 0.000 description 23
- 150000003254 radicals Chemical class 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 7
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 7
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 6
- GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- UOORRWUZONOOLO-OWOJBTEDSA-N (E)-1,3-dichloropropene Chemical compound ClC\C=C\Cl UOORRWUZONOOLO-OWOJBTEDSA-N 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- UOORRWUZONOOLO-UHFFFAOYSA-N telone II Natural products ClCC=CCl UOORRWUZONOOLO-UHFFFAOYSA-N 0.000 description 5
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 4
- 230000029936 alkylation Effects 0.000 description 4
- 238000005804 alkylation reaction Methods 0.000 description 4
- PPXUHEORWJQRHJ-UHFFFAOYSA-N ethyl isovalerate Chemical compound CCOC(=O)CC(C)C PPXUHEORWJQRHJ-UHFFFAOYSA-N 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 230000005595 deprotonation Effects 0.000 description 3
- 238000010537 deprotonation reaction Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical class CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- 150000005840 aryl radicals Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229940043279 diisopropylamine Drugs 0.000 description 2
- 239000012039 electrophile Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- OVEHNNQXLPJPPL-UHFFFAOYSA-N lithium;n-propan-2-ylpropan-2-amine Chemical compound [Li].CC(C)NC(C)C OVEHNNQXLPJPPL-UHFFFAOYSA-N 0.000 description 2
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 125000005490 tosylate group Chemical group 0.000 description 2
- 150000008648 triflates Chemical class 0.000 description 2
- PPKPKFIWDXDAGC-NSCUHMNNSA-N (e)-1,2-dichloroprop-1-ene Chemical compound C\C(Cl)=C/Cl PPKPKFIWDXDAGC-NSCUHMNNSA-N 0.000 description 1
- NOPVMHYFCPFLOH-HWKANZROSA-N (e)-5-chloro-2-propan-2-ylpent-4-enoic acid Chemical compound CC(C)C(C(O)=O)C\C=C\Cl NOPVMHYFCPFLOH-HWKANZROSA-N 0.000 description 1
- 125000005919 1,2,2-trimethylpropyl group Chemical group 0.000 description 1
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006039 1-hexenyl group Chemical group 0.000 description 1
- 125000006023 1-pentenyl group Chemical group 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- VFTFKUDGYRBSAL-UHFFFAOYSA-N 15-crown-5 Chemical compound C1COCCOCCOCCOCCO1 VFTFKUDGYRBSAL-UHFFFAOYSA-N 0.000 description 1
- FALCMQXTWHPRIH-UHFFFAOYSA-N 2,3-dichloroprop-1-ene Chemical compound ClCC(Cl)=C FALCMQXTWHPRIH-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- NJBCRXCAPCODGX-UHFFFAOYSA-N 2-methyl-n-(2-methylpropyl)propan-1-amine Chemical compound CC(C)CNCC(C)C NJBCRXCAPCODGX-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000006041 3-hexenyl group Chemical group 0.000 description 1
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- 125000006042 4-hexenyl group Chemical group 0.000 description 1
- 125000006043 5-hexenyl group Chemical group 0.000 description 1
- OSDWBNJEKMUWAV-UHFFFAOYSA-N Allyl chloride Chemical compound ClCC=C OSDWBNJEKMUWAV-UHFFFAOYSA-N 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 238000003512 Claisen condensation reaction Methods 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- 238000005937 allylation reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HWYQPOCXHSDIHD-UHFFFAOYSA-N ethyl 4-chloro-2-propan-2-ylpent-4-enoate Chemical compound CCOC(=O)C(C(C)C)CC(Cl)=C HWYQPOCXHSDIHD-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- UPTHEJMPARMRJA-UHFFFAOYSA-N lithium;bis(1-adamantyl)azanide Chemical compound [Li+].C1C(C2)CC(C3)CC2CC13[N-]C(C1)(C2)CC3CC2CC1C3 UPTHEJMPARMRJA-UHFFFAOYSA-N 0.000 description 1
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 1
- AHNJTQYTRPXLLG-UHFFFAOYSA-N lithium;diethylazanide Chemical compound [Li+].CC[N-]CC AHNJTQYTRPXLLG-UHFFFAOYSA-N 0.000 description 1
- RZYQVFNZQTZPKQ-UHFFFAOYSA-N lithium;ditert-butylazanide Chemical compound [Li+].CC(C)(C)[N-]C(C)(C)C RZYQVFNZQTZPKQ-UHFFFAOYSA-N 0.000 description 1
- CETVQRFGPOGIQJ-UHFFFAOYSA-N lithium;hexane Chemical compound [Li+].CCCCC[CH2-] CETVQRFGPOGIQJ-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000010327 methods by industry Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000001298 n-hexoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- UYYCVBASZNFFRX-UHFFFAOYSA-N n-propan-2-ylcyclohexanamine Chemical compound CC(C)NC1CCCCC1 UYYCVBASZNFFRX-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001979 organolithium group Chemical group 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- UKODFQOELJFMII-UHFFFAOYSA-N pentamethyldiethylenetriamine Chemical compound CN(C)CCN(C)CCN(C)C UKODFQOELJFMII-UHFFFAOYSA-N 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/363—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
Definitions
- the present invention relates to a process for the preparation of substituted in 2-position carboxylic acids by alkylation of the corresponding dianions of the carboxylic acid used.
- the invention further relates to a process for the preparation of the corresponding carboxylic acid derivatives, especially the corresponding carboxylic esters by esterification of the produced ⁇ -substituted carboxylic acids.
- Alkylation of carboxylic acid esters by deprotonation with strong bases and trapping of the metal enolate with electrophiles is an important transformation of organic synthetic chemistry.
- Deprotonation is typically conducted at very low temperatures, often at -78 ° C. In order to avoid unwanted side reactions, especially the Claisen condensation, it is customarily allowed to warm up to room temperature only after addition of the electrophile, as described by W. Dai, for example. in J. Org. Chem. 1993, 58, 1900-1908.
- DMPU dimethylpropyleneurea
- HMPT hexamethylphosphoric acid triamide
- the carboxylic acids selected as starting materials can also be converted into the corresponding dianions by addition of a sufficient amount of a strong base and then alkylated.
- This synthesis variant is also carried out to obtain satisfactory yields, usually in the presence of complexing agents such as HMPT or DMPU.
- 2-substituted isovaleric acids are in principle accessible in this way. They represent important intermediates for the production of active pharmaceutical ingredients.
- WO 01/09079 discloses a process for the preparation of 2-alkyl-5-halogen-pent-4-enecarboxylic acids and their acid derivatives such as their esters by alkylation of the corresponding ester enolates with allyl halides.
- the reaction of ethyl isovalerate with lithium diisopropylamide to give the corresponding ester enolate and subsequent reaction with trans-1,3-dichloropropene is described by way of example.
- the reaction is carried out in the presence of potassium iodide and DMPU as cosolvent at -20 ° C.
- US 4,492,799 discloses a process for the preparation of ethyl 4-chloro-2-isopropyl-4-pentenoate by deprotonation of ethyl isovalerate with lithium diisopropylpropamide and subsequent reaction with 2,3-dichloro-1-propene at temperatures from -78 ° C to -30 ° C C.
- the target compound was obtained in a yield of 46% of theory receive.
- the conversion of a carboxylic acid into its dianion followed by allylation is described schematically.
- the object underlying the present invention was to provide a process for the one-stage preparation of 2-substituted carboxylic acids which can be carried out under conditions which are as advantageous as possible in the process, especially at advantageously realizable temperatures and avoiding undesired additives or solvents.
- the formation of undesirable by-products should be avoided as far as possible.
- R 1 is hydrogen or unbranched, branched or cyclic C 1 to C 6 alkyl
- R 2 is unbranched or branched C 1 to C 6 alkyl or C 1 to C 6 alkenyl or
- R 1 has the same meaning as in formula (I),
- R 2 has the same meaning as in formula (I) and
- X represents chlorine, bromine, iodine, triflate, tosylate or mesylate.
- radical R 1 is hydrogen or straight-chain, branched or cyclic C 1 - to C 6 -alkyl and the radical R 2 is unbranched or branched C 1 - to C 6 -alkyl or C 2 - to C 6 -alkenyl or benzyl
- the said Radicals may have one or more identical or different substituents selected from the group of the substituents chlorine, bromine, iodine, alkoxy, thioalkyl, dialkylamino, diarylamino and aryl.
- C 1 to C 6 alkyl are to be understood as meaning alkyl radicals having 1 to 6 carbon atoms, such as, for example: methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1, 1-dimethylethyl, Pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1, 1-dimethylpropyl, 1, 2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3 Methylpentyl, 4-methylpentyl,
- C2- to C ⁇ -alkenyl in the context of the present invention represents a mono- or polyethylenically unsaturated radical having 2 to 6 carbon atoms, such as, for example: ethenyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl and 5-hexenyl.
- the radicals mentioned can, if possible, be present in each case in the cis or trans or the E or Z configuration with respect to the double bonds present.
- radicals mentioned may contain one or more, usually 1 or 2, identical or different substituents selected from the group of the substituents chlorine, bromine, iodine, alkoxy, thioalkyl, dialkylamino, diarylamino and aryl, preferably chlorine , exhibit.
- alkoxy is preferably a C 1 - to C 6 -alkyl radical bonded via an oxygen atom, as described above, particularly preferably methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, tert-butoxy, n-pentoxy or n-hexoxy.
- thioalkyl is preferably a bonded via a sulfur, as described above d- to C ⁇ -alkyl radical.
- dialkylamino is taken to mean amino substituents having two identical or different alkyl radicals, preferably as described above, to C 5 -alkyl radicals, for example dimethylamino or diethylamino.
- aryl denotes in the context of the present invention an aryl radical having 6 to 14 carbon atoms, preferably optionally substituted phenyl.
- diarylamino is understood to mean an amino substituent having two identical or different aryl radicals.
- radicals R 1 may be mentioned: isopropyl, isobutyl, tert. Butyl, sec. Butyl, most preferably isopropyl.
- Preferred radicals R 2 according to the invention are chlorine-substituted propenyl radicals, for example 3-chloropropen-1-yl, 2-chloropropen-1-yl, 1-chloropropen-3-yl, 2-chloropropene-3 Particularly preferred is trans-1-chloro-propen-3-yl.
- the starting compounds to be used according to the invention are compounds of the formula (II)
- R 1 has the same meaning as for the desired target compound of the formula (I).
- R 1 in formula (II) is unbranched or branched Cr to Ce-alkyl.
- step a) of the process according to the invention the starting compounds of the formula (I) are reacted with from about 1.8 to about 2.5 molar equivalents, preferably from about 1.9 to about 2.2 molar equivalents, more preferably about 2.0 mol equivalents (based on the amount of acid to be deprotonated of the formula (M)) base, preferably with the stated amounts of a strong base to.
- the term strong base means those bases which are capable, ie strong enough, of converting a carboxylic acid into its corresponding dianion (ie into the enolate of the corresponding carboxylate), in particular those whose conjugated acid has a pK a value of about 26 or above, preferably about 30 or above, and more preferably having a pK a of from about 35 to about 50, especially to about 45, such as lithium alkyls such as methyllithium, butyl lithium, phenyllithium, alkali metals such as lithium, sodium or potassium, or amine bases such as, for example, potassium hexamethyldisilazide, sodium hexamethyldisilazide, lithium hexamethyldisilazide, lithium diisopropylamide, lithium diethylamide, lithium di-tert-butylamide, lithium di-adamantylamide, lithium 2,2,6,6-tetramethylethylpiperidide.
- the carboxylic acid of the formula (II) is reacted according to step a) first by treatment with a base, preferably with about 0.8 to about 1.2 mol equivalents, more preferably with about 1 molar equivalent of a weak base capable of deprotonating a carboxylic acid group into the corresponding carboxylate of the formula (IV)
- the amount of strong base to be used is expediently chosen so that the carboxylic acid used or the intermediate carboxylate of the formula (IV) is converted as completely as possible into the dianion, ie the enolate of the carboxylate.
- about 0.8 to about 1.3 molar equivalents preferably from about 0.9 to about 1.1 molar equivalents, more preferably 1 molar equivalent of the selected strong base.
- Preferred strong bases according to the invention are metallated dialkylamines of the formula (V)
- M is lithium, sodium or potassium, preferably lithium and the radicals R 3 and R 4 are identical or different and are an unbranched, branched or cyclic C 1 to C 6 alkyl radical or a trialkylsilyl radical, for example trimethylsilyl.
- metallated, preferably lithiated, dialkylamines can be prepared by methods known per se to the person skilled in the art, for example by treatment of a corresponding dialkylamine, such as, for example, diisopropylamine, diisobutylamine or isopropylcyclohexylamine, with a suitable lithium alkyl such as, for example,
- Butyllithium, s-butyllithium, tert-butyllithium, n-hexyllithium, methyllithium or phenyl lithium Such processes are described in detail, for example, in "The Practice of the Organic Chemist", Gattermann, Wieland, newly edited by T. Wieland and W. Sucrow, 43rd ed., Berlin-New York, Walter de Gruyter Furthermore, solutions of such bases
- a particularly preferred strong base according to the invention is lithium diisoproylamine (LDA).
- the reaction according to step a) of the present invention is advantageously carried out by preparing a solution of the chosen strong base, preferably the chosen lithiated dialkylamine in a suitable solvent such as tetrahydrofuran, dioxane, dimethoxyethane or other cyclic or acyclic ethers. This is usually done at temperatures of about -80 ° C to about 0 ° C, preferably from about -60 ° C to about 0 ° C, more preferably about -40 ° C to about 0 ° C, and most preferably about -20 ° C to about 0 ° C by adding the selected organolithium reagent to the selected dialkylamine.
- a suitable solvent such as tetrahydrofuran, dioxane, dimethoxyethane or other cyclic or acyclic ethers.
- the selected starting compound of the formula (I) is then usually added to the prepared solution of the strong base.
- the addition and the subsequent reaction of the carboxylic acid of the formula (I) with the selected strong base is preferably carried out at temperatures of about -20.degree. C. to about 0.degree.
- a dropping time of usually about 10 minutes to about 1 hour the formation of the carboxylic acid dione is usually rapid, usually after about 2 hours, often after about 1 hour.
- step b) of the process according to the invention the intermediate product or product mixture obtained in step a) is reacted with a compound of the formula (III) R 2 - X (III)
- radical R 2 has the same meaning as in the target compound of the formula (I) and X is chlorine, bromine or iodine, triflate, tosylate or mesylate, preferably chlorine.
- the compounds of the formula (III) are alkyl or alkenyl halides or triflates, mesylates or tosylates having up to 6 carbon atoms or benzyl halides or triflates, methylates or tosylates, each of which is further as described for the radical R 2 may have substituents.
- Preferred compounds of the formula (III) according to the invention are allyl halides, in particular allyl halides such as, for example, allyl chloride, allyl bromide, 1,3-dichloropropene, 1,2-dichloropropene, 3-chloroallyl mesylate, 3-chloroallyl triflate, 3-chloroallyl tosylate, particularly preferably trans-1 , 3-dichloropropene.
- allyl halides such as, for example, allyl chloride, allyl bromide, 1,3-dichloropropene, 1,2-dichloropropene, 3-chloroallyl mesylate, 3-chloroallyl triflate, 3-chloroallyl tosylate, particularly preferably trans-1 , 3-dichloropropene.
- step b) is advantageously carried out by adding the selected compound of the formula (III) to the solution of the double-deprotonated carboxylic acid prepared in step a) preferably at a temperature of about -20.degree. C. to about 0.degree , It may be advantageous to use the selected compound of the formula (III) in a slight molar excess with respect to the carboxylic acid dianion or the starting compound of the formula (M), especially in a molar ratio of from about 1: 1 to about 2: 1 about 1.05 to 1 to about 1.3: 1.
- the formation of the desired product of the formula (I) in the abovementioned temperature range is usually completed after about 1 to about 24 hours, often after about 3 to about 6 hours.
- the products or product mixtures obtained can subsequently be worked up, isolated or further purified by methods known to those skilled in the art.
- the reaction according to the invention in step b) can be successfully carried out while substantially avoiding complexing agents or co-solvents such as hexamethylphosphoric triamide (HMPT), dimethylpropylene urea (DMPU), tetramethylethylenediamine (TMEDA), pentamethyldiethylenetriamine, crown ethers, for example.
- HMPT hexamethylphosphoric triamide
- DMPU dimethylpropylene urea
- TEDA tetramethylethylenediamine
- pentamethyldiethylenetriamine crown ethers
- B. 15-crown-5, DMF, potassium tert-butoxide can be performed.
- the reaction is preferably carried out in the presence of up to about 0.25 equivalents, more preferably of up to 0.2 and more preferably of up to about 0.1 equivalents of the particular complexing agent, based on the molar amount of base used.
- the reaction according to step a) and / or step b) is carried out without addition, ie in the absence of complexing agents or cosolvents, particularly preferably in the absence of HMPT.
- the present invention relates to a process for the preparation of compounds of the formula (Ia)
- R 1 ' may have the same meanings as R 1 in formula (I), preferably isopropyl and Z is chlorine, bromine or iodine, preferably chlorine, comprising the steps
- R 1 has the same meaning as in formula (Ia), with 1, 8 to 2.5 mol equivalents of a base as described above and
- Z has the same meaning as in formula (Ia) and Z 'may be the same or different from Z and chlorine, bromine or iodine, preferably chlorine.
- ⁇ -substituted carboxylic acids of the formula (I) or (Ia) obtainable by the process according to the invention can in turn be esterified by methods known to the person skilled in the art, for example by acid catalysis in the presence of an alcohol.
- carboxylic acids which can be prepared according to the invention are also suitable for the preparation of any further carboxylic acid derivatives such as, for example, carboxylic acid amides, hydrazides, azides, nitriles, orthoesters and carboxylic acid halides.
- carboxylic acid derivatives such as, for example, carboxylic acid amides, hydrazides, azides, nitriles, orthoesters and carboxylic acid halides.
- derivatizations are known to the person skilled in the art and are described, for example, in Organikum, Organisch-Chemisches Grundpraktikum, 20th Edition, Wiley-VCH Verlag Weinheim, Chapter 7.
- the present invention therefore also relates to a process for the preparation of carboxylic acid derivatives of the formula (VI)
- R 1 , R 2 may have the meanings given in formula (I) and
- R 5 is a straight-chain, branched and / or cyclic C 1 - to C 12 -alkyl radical or C 7 - to C 12 -aralkyl radical and
- R 6, R 7 are independently hydrogen or a straight-chain, branched and / or cyclic d- to Ci2-alkyl or C7 to C12 aralkyl group mean
- the present invention relates to processes for the preparation of carboxylic acid esters of the formula (VII)
- R 1 , R 2 may have the meanings given in formula (I) and
- R 5 represents a straight-chain, branched and / or cyclic C 1 - to C 12 -alkyl radical or C 7 - to C 12 -aralkyl radical
- C 1 - to C 12 -alkyl denotes a straight-chain or branched alkyl radical having 1 to 12 carbon atoms, for example as mentioned above for C 1 - to C 6 -alkyl and furthermore also heptyl, octyl, nonyl, decyl, dodecyl.
- Cj- to C12-aralkyl is an attached via an alkyl radical having at least one carbon atom
- Phenyl for example benzyl, 1-phenylethyl or 2-phenylethyl.
- Halogen is fluorine, chlorine, bromine or iodine, preferably fluorine, chlorine or bromine. Accordingly, the process according to the invention provides attractive access to carboxylic acids substituted in the 2-position and their esters starting from the usually readily accessible unsubstituted carboxylic acids.
- a particular advantage of the method according to the invention is that it can be carried out in procedurally and economically advantageous conditions, especially while avoiding low temperatures and while avoiding additional procedurally and toxicologically problematic reagents.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention relates to a method for producing carboxylic acids substituted in the 2-position by alkylating the respective dianions of the used carboxylic acid. The invention further relates to a method for producing the corresponding carboxylic acid derivatives, especially the corresponding carboxylic acid esters by esterifying the produced α-substituted carboxylic acids.
Description
Verfahren zur Herstellung von α-substituierten CarbonsäurenProcess for the preparation of α-substituted carboxylic acids
Beschreibungdescription
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von in 2-Position substituierten Carbonsäuren durch Alkylierung der entsprechenden Dianionen der eingesetzten Carbonsäure. Die Erfindung betrifft darüber hinaus ein Verfahren zur Herstellung der entsprechenden Carbonsäurederivate, speziell der entsprechenden Carbonsäureester durch Veresterung der hergestellten α-substituierten Carbonsäuren.The present invention relates to a process for the preparation of substituted in 2-position carboxylic acids by alkylation of the corresponding dianions of the carboxylic acid used. The invention further relates to a process for the preparation of the corresponding carboxylic acid derivatives, especially the corresponding carboxylic esters by esterification of the produced α-substituted carboxylic acids.
Die Alkylierung von Carbonsäurestern durch Deprotonierung mit starken Basen und Abfangen des Metallenolats mit Elektrophilen stellt eine wichtige Transformation der organischen Synthesechemie dar. Die Deprotonierung wird typischerweise bei sehr tiefen Temperaturen, oft bei -78°C durchgeführt. Zur Vermeidung unerwünschter Ne- benreaktionen, speziell der Claisenkondensation lässt man üblicherweise erst nach Zugabe des Elektrophils auf Raumtemperatur aufwärmen, wie beispielsweise von W. Dai etw al. in J. Org. Chem. 1993, 58, 1900-1908 beschrieben. Je nach Wahl der eingesetzten nicht-nucleophilen Base werden dem Reaktionsgemisch oft Komplexbildner wie beispielsweise Dimethylpropylenharnstoff (DMPU) oder Hexamethylphosphorsäu- retriamid (HMPT) zugesetzt, die aus verfahrenstechnischer wie toxikologische Sicht nicht unbedenklich sind.Alkylation of carboxylic acid esters by deprotonation with strong bases and trapping of the metal enolate with electrophiles is an important transformation of organic synthetic chemistry. Deprotonation is typically conducted at very low temperatures, often at -78 ° C. In order to avoid unwanted side reactions, especially the Claisen condensation, it is customarily allowed to warm up to room temperature only after addition of the electrophile, as described by W. Dai, for example. in J. Org. Chem. 1993, 58, 1900-1908. Depending on the choice of non-nucleophilic base used, complexing agents such as dimethylpropyleneurea (DMPU) or hexamethylphosphoric acid triamide (HMPT) are often added to the reaction mixture, which are not safe from a process engineering and toxicological point of view.
Zur gezielten einstufigen Synthese von α-substituierten Carbonsäuren lassen sich die als Ausgangsstoffe gewählten Carbonsäuren auch durch Zugabe einer ausreichenden Menge einer starken Base in die entsprechenden Dianionen überführen und anschließend alkylieren. Auch diese Synthesevariante wird zur Erzielung zufriedenstellender Ausbeuten üblicherweise in Gegenwart von Komplexbildnern wie HMPT oder DMPU durchgeführt.For the targeted one-step synthesis of α-substituted carboxylic acids, the carboxylic acids selected as starting materials can also be converted into the corresponding dianions by addition of a sufficient amount of a strong base and then alkylated. This synthesis variant is also carried out to obtain satisfactory yields, usually in the presence of complexing agents such as HMPT or DMPU.
Auch 2-substituierte Isovaleriansäuren sind prinzipiell auf diesem Wege zugänglich. Sie stellen wichtige Zwischenprodukte für die Herstellung von Pharmawirkstoffen dar.2-substituted isovaleric acids are in principle accessible in this way. They represent important intermediates for the production of active pharmaceutical ingredients.
Stand der Technik:State of the art:
Die WO 01/09079 offenbart ein Verfahren zur Herstellung von 2-Alkyl-5-halogen-pent- 4-en-carbonsäuren sowie deren Säurederivate wie z.B. deren Ester durch Alkylierung der entsprechenden Esterenolate mit Allylhalogeniden. Beispeilhaft wird die Umsetzung von Isovaleriansäureethylester mit Lithiumdiisopropylamid zum entsprechenden Esterenolat und anschließender Umsetzung mit trans-1 ,3-Dichlorpropen beschrieben. Die Reaktion wird in Gegenwart von Kaliumiodid und DMPU als Cosolvens bei -20°C durchgeführt.
Die US 4,492,799 offenbart ein Verfahren zur Herstellung von 4-Chlor-2-ispropyl-4- pentensäureethylester durch Deprotonierung von Isovaleriansäureethylester mit Lithiumdiisppropylamid und anschließender Umsetzung mit 2,3-Dichlor-1-propen bei Temperaturen von -78°C bis -30°C. Die Zielverbindung wurde in einer Ausbeute von 46 % d.Th. erhalten. Darüber hinaus wird auch die Überführung einer Carbonsäure in ihr Dianion mit anschließender Allylierung schematisch beschrieben.WO 01/09079 discloses a process for the preparation of 2-alkyl-5-halogen-pent-4-enecarboxylic acids and their acid derivatives such as their esters by alkylation of the corresponding ester enolates with allyl halides. The reaction of ethyl isovalerate with lithium diisopropylamide to give the corresponding ester enolate and subsequent reaction with trans-1,3-dichloropropene is described by way of example. The reaction is carried out in the presence of potassium iodide and DMPU as cosolvent at -20 ° C. US 4,492,799 discloses a process for the preparation of ethyl 4-chloro-2-isopropyl-4-pentenoate by deprotonation of ethyl isovalerate with lithium diisopropylpropamide and subsequent reaction with 2,3-dichloro-1-propene at temperatures from -78 ° C to -30 ° C C. The target compound was obtained in a yield of 46% of theory receive. In addition, the conversion of a carboxylic acid into its dianion followed by allylation is described schematically.
P. Pfeffer et al beschreiben in J. Org. Chem. 1972, 451 - 459 ein Verfahren zur Herstellung von α-Alkyl-Carbonsäuren durch Bildung des Carbonsäure-enolat-Dianions und schließende Alkylierung in Gegenwart von HMPT.P. Pfeffer et al. In J. Org. Chem. 1972, 451-459 describe a process for the preparation of α-alkyl carboxylic acids by formation of the carboxylic acid enolate dianion and subsequent alkylation in the presence of HMPT.
Aufgabe der Erfindung:Object of the invention:
Die der vorliegenden Erfindung zu Grunde liegende Aufgabe bestand in der Bereitstel- lung eines Verfahrens zur einstufigen Herstellung von 2-substituierten Carbonsäuren, dass unter verfahrenstechnisch möglichst vorteilhaften Bedingungen, speziell bei vorteilhaft realisierbaren Temperaturen und unter Vermeidung unerwünschter Zusatzstoffe oder Lösungsmittel durchgeführt werden kann. Dabei soll die Bildung unerwünschter Nebenprodukte weitestgehend vermieden werden.The object underlying the present invention was to provide a process for the one-stage preparation of 2-substituted carboxylic acids which can be carried out under conditions which are as advantageous as possible in the process, especially at advantageously realizable temperatures and avoiding undesired additives or solvents. The formation of undesirable by-products should be avoided as far as possible.
Beschreibung der Erfindung sowie der bevorzugten Ausführungsformen:DESCRIPTION OF THE INVENTION AND THE PREFERRED EMBODIMENTS
Die Aufgabe wurde erfindungsgemäß gelöst durch die Bereitstellung eines Verfahrens zur Herstellung einer Carbonsäure der Formel (I)The object has been achieved according to the invention by the provision of a process for preparing a carboxylic acid of the formula (I)
wobeiin which
R1 Wasserstoff oder unverzweigtes, verzweigtes oder cyclisches d- bis Cβ-Alkyl undR 1 is hydrogen or unbranched, branched or cyclic C 1 to C 6 alkyl and
R2 unverzweigtes oder verzweigtes d- bis Cβ-Alkyl oder d- bis Cδ-Alkenyl oderR 2 is unbranched or branched C 1 to C 6 alkyl or C 1 to C 6 alkenyl or
Benzyl bedeutet , wobei die genannten Reste einen oder mehrere gleiche oder verschiedene Substituenten, ausgewählt aus der Gruppe der SubstituentenBenzyl, wherein said radicals one or more identical or different substituents selected from the group of substituents
Chlor, Brom, Jod, Alkoxy, Thioalkyl, Dialkylamino, Diarylamino und Aryl aufweisen können,Chlorine, bromine, iodine, alkoxy, thioalkyl, dialkylamino, diarylamino and aryl,
umfassend die Schritte
a) Umsetzung einer Carbonsäure der Formel (II)comprising the steps a) reaction of a carboxylic acid of the formula (II)
.OH (M) .OH (M)
R1 R 1
OO
wobeiin which
R1 die gleiche Bedeutung wie in Formel (I) besitzt,R 1 has the same meaning as in formula (I),
mit 1 ,8 bis 2,5 mol-Äquivalenten mindestens einer Base undwith 1, 8 to 2.5 molar equivalents of at least one base and
b) Umsetzung des in Schritt a) erhaltenen Produktes mit einer Verbindung der Formel (IM)b) reaction of the product obtained in step a) with a compound of the formula (III)
R2 — X (IM)R 2 - X (IM)
wobeiin which
R2 die gleiche Bedeutung wie in Formel (I) besitzt undR 2 has the same meaning as in formula (I) and
X Chlor, Brom, Jod, Triflat, Tosylat oder Mesylat bedeutet.X represents chlorine, bromine, iodine, triflate, tosylate or mesylate.
Das erfindungsgemäße Verfahren ermöglicht die Herstellung von Carbonsäuren der Formel (I)The process according to the invention enables the preparation of carboxylic acids of the formula (I)
R1 R 1
ausgehend von Carbonsäuren der Formel (M)starting from carboxylic acids of the formula (M)
OH (M) OH (M)
R1 R 1
OO
wobei der Rest R1 für Wasserstoff oder für unverzweigtes, verzweigtes oder cyclisches d- bis Cβ-Alkyl steht und der Rest R2 für unverzweigtes oder verzweigtes d- bis Ce- Alkyl oder C2- bis Cβ-Alkenyl oder Benzyl bedeutet , wobei die genannten Reste einen oder mehrere gleiche oder verschiedene Substituenten, ausgewählt aus der Gruppe der Substituenten Chlor, Brom, Jod, Alkoxy, Thioalkyl, Dialkylamino, Diarylamino und Aryl aufweisen können, steht.
Unter dem Begriff d- bis Cβ-Alkyl sind dabei Alkylreste mit 1 bis 6 Kohlenstoffatomen zu verstehen wie beispielsweise: Methyl, Ethyl, Propyl, 1-Methylethyl, Butyl, 1-Methyl- propyl, 2-Methylpropyl, 1 ,1-Dimethylethyl, Pentyl, 1-Methylbutyl, 2-Methylbutyl, 3-Methylbutyl, 2,2-Di-methylpropyl, 1-Ethylpropyl, Hexyl, 1 ,1-Dimethylpropyl, 1 ,2- Dimethylpropyl, 1-Methylpentyl, 2-Methylpentyl, 3-Methylpentyl, 4-Methylpentyl,where the radical R 1 is hydrogen or straight-chain, branched or cyclic C 1 - to C 6 -alkyl and the radical R 2 is unbranched or branched C 1 - to C 6 -alkyl or C 2 - to C 6 -alkenyl or benzyl, where the said Radicals may have one or more identical or different substituents selected from the group of the substituents chlorine, bromine, iodine, alkoxy, thioalkyl, dialkylamino, diarylamino and aryl. The term C 1 to C 6 alkyl are to be understood as meaning alkyl radicals having 1 to 6 carbon atoms, such as, for example: methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1, 1-dimethylethyl, Pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1, 1-dimethylpropyl, 1, 2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3 Methylpentyl, 4-methylpentyl,
1 ,1-Dimethylbutyl, 1 ,2-Dimethylbutyl, 1 ,3-Dimethylbutyl, 2,2-Dimethylbutyl, 2,3-Dime- thylbutyl, 3,3-Dimethylbutyl, 1-Ethylbutyl, 2-Ethylbutyl, 1 ,1 ,2-Trimethylpropyl, 1 ,2,2- Trimethylpropyl, 1-Ethyl-1-methylpropyl,1-Ethyl-2-methylpropyl, Cyclopropyl, Cyclopen- tyl und Cyclohexyl.1, 1-dimethylbutyl, 1, 2-dimethylbutyl, 1, 3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1, 1, 2-trimethylpropyl, 1, 2,2-trimethylpropyl, 1-ethyl-1-methylpropyl, 1-ethyl-2-methylpropyl, cyclopropyl, cyclopentyl and cyclohexyl.
C2- bis Cδ-Alkenyl steht im Rahmen der vorliegenden Erfindung für einen einfach oder mehrfach ethylenisch ungesättigten Rest mit 2 bis 6 Kohlenstoffatomen wie beispielsweise: Ethenyl, 1-Propenyl, 2-Propenyl, 1-Butentyl, 2-Butenyl, 3-Butenyl, 1-Pentenyl, 2-Pentenyl, 3-Pentenyl, 4-Pentenyl, 1-Hexenyl, 2-Hexenyl, 3-Hexenyl, 4-Hexenyl und 5-Hexenyl. Die genannten Reste können, falls möglich, jeweils in der eis- oder trans- bzw. der E- oder Z-Konfiguration bezüglich der vorhandenen Doppelbindungen vorliegen.C2- to Cδ-alkenyl in the context of the present invention represents a mono- or polyethylenically unsaturated radical having 2 to 6 carbon atoms, such as, for example: ethenyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl and 5-hexenyl. The radicals mentioned can, if possible, be present in each case in the cis or trans or the E or Z configuration with respect to the double bonds present.
Im Fall des Restes R2 können genannten Reste einen oder mehrere, in der Regel 1 oder 2 gleiche oder verschiedene Substituenten, ausgewählt aus der Gruppe der Sub- stituenten Chlor, Brom, Jod, Alkoxy, Thioalkyl, Dialkylamino, Diarylamino und Aryl, bevorzugt Chlor, aufweisen.In the case of the radical R 2 , the radicals mentioned may contain one or more, usually 1 or 2, identical or different substituents selected from the group of the substituents chlorine, bromine, iodine, alkoxy, thioalkyl, dialkylamino, diarylamino and aryl, preferably chlorine , exhibit.
Dabei steht Alkoxy bevorzugt für einen über ein Sauerstoffatom gebundenen, wie vor- stehend beschriebenen d- bis Cδ-Alkylrest, besonders bevorzugt für Methoxy, Ethoxy, n-Propoxy, iso-Propoxy, n-Butoxy, sec-Butoxy, tert-Butoxy, n-Pentoxy oder n-Hexoxy. Der Begriff Thioalkyl steht bevorzugt für einen über ein Schwefelarom gebundenen, wie vorstehend beschrieben d- bis Cδ-Alkylrest. Unter dem Begriff Dialkylamino sind Aminosubstituenten mit zwei gleichen oder verschiedenen Alkylresten, bevorzugt wie vorstehend beschriebenen d- bis Cδ-Alkylresten zu verstehen , wie beispielsweise Dimethylamino oder Diethylamino. Der Begriff Aryl bezeichnet im Rahmen der vorliegenden Erfindung einen Arylrest mit 6 bis 14 Kohlenstoffatomen, bevorzugt gegebenenfalls substituertes Phenyl. Unter dem Begriff Diarylamino ist ein Aminosubstituent mit zwei gleichen oder verschiedenen Arylresten zu verstehen.In this case, alkoxy is preferably a C 1 - to C 6 -alkyl radical bonded via an oxygen atom, as described above, particularly preferably methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, tert-butoxy, n-pentoxy or n-hexoxy. The term thioalkyl is preferably a bonded via a sulfur, as described above d- to Cδ-alkyl radical. The term dialkylamino is taken to mean amino substituents having two identical or different alkyl radicals, preferably as described above, to C 5 -alkyl radicals, for example dimethylamino or diethylamino. The term aryl denotes in the context of the present invention an aryl radical having 6 to 14 carbon atoms, preferably optionally substituted phenyl. The term diarylamino is understood to mean an amino substituent having two identical or different aryl radicals.
Als im Rahmen der vorliegenden Erfindung bevorzugte Reste R1 seien genannt: Isopropyl, Isobuyl, tert. -Butyl, sek. -Butyl, besonders bevorzugt Isopropyl.As in the context of the present invention preferred radicals R 1 may be mentioned: isopropyl, isobutyl, tert. Butyl, sec. Butyl, most preferably isopropyl.
Erfindungsgemäß bevorzugte Reste R2 sind chlorsubstituierte Propenylreste wie bei- spielsweise 3-Chlor-Propen-1-yl, 2-Chlor-Propen-1-yl, 1-Chlor-Propen-3-yl, 2-Chlor- Propen-3-yl besonders bevorzugt trans-1-Chlor-Propen-3-yl.
Als erfindungsgemäß einzusetzende Ausgangsverbindungen dienen Verbindungen der Formel (II)Preferred radicals R 2 according to the invention are chlorine-substituted propenyl radicals, for example 3-chloropropen-1-yl, 2-chloropropen-1-yl, 1-chloropropen-3-yl, 2-chloropropene-3 Particularly preferred is trans-1-chloro-propen-3-yl. The starting compounds to be used according to the invention are compounds of the formula (II)
R1 °H <">R 1 ° H <">
OO
wobei dem Rest R1 die gleiche Bedeutung wie für die gewünschte Zielverbindung der Formel (I) zukommt. Bevorzugt steht R1 in Formel (II) für unverzweigtes oder verzweigtes Cr bis Ce-Alkyl.wherein the radical R 1 has the same meaning as for the desired target compound of the formula (I). Preferably, R 1 in formula (II) is unbranched or branched Cr to Ce-alkyl.
Gemäß Schritt a) des erfindungsgemäßen Verfahrens setzt man die Ausgangsverbindungen der Formel (I) mit etwa 1 ,8 bis etwa 2,5 mol-Äquivalenten, bevorzugt etwa 1 ,9 bis etwa 2,2 mol-Äquivalenten, besonders bevorzugt etwa 2,0 mol-Äquivalenten (bezogen auf die eingesetzte Menge an zu deprotonierender Säure der Formel (M)) Base, bevorzugt mit den genannten Mengen einer starken Base um. Unter dem Begriff starke Base sind prinzipiell solche Base zu verstehen, die befähigt, d.h. stark genug sind, eine Carbonsäure in ihr entsprechendes Dianion (d.h. in das Enolat des entprechenden Carboxylats) zu überführen, insbesondere solche, deren konjugierte Säure einen pKa- Wert von etwa 26 oder darüber, bevorzugt etwa 30 oder darüber und besonders bevorzugt einen pKa-Wert von etwa 35 bis etwa 50, insbesondere bis etwa 45 aufweisen, wie beispielsweise Lithiumalkyle wie z.B. Methyllithium, Butyllithium, Phenyllithium, Alkalimetalle wie Lithium, Natrium oder Kalium, oder Aminbasen wie z.B. Kaliumhexa- methyldisilazid, Natriumhexamethyldisilazid, Lithiumhexamethyldisilazid, Lithiumdiisopropylamid, Lithiumdiethylamid, Lithiumdi-tert-butylamid, Lithiumdi-ada- mantylamid, Lithium-2,2,6,6,-tetramethylethylpiperidid.In accordance with step a) of the process according to the invention, the starting compounds of the formula (I) are reacted with from about 1.8 to about 2.5 molar equivalents, preferably from about 1.9 to about 2.2 molar equivalents, more preferably about 2.0 mol equivalents (based on the amount of acid to be deprotonated of the formula (M)) base, preferably with the stated amounts of a strong base to. In principle, the term strong base means those bases which are capable, ie strong enough, of converting a carboxylic acid into its corresponding dianion (ie into the enolate of the corresponding carboxylate), in particular those whose conjugated acid has a pK a value of about 26 or above, preferably about 30 or above, and more preferably having a pK a of from about 35 to about 50, especially to about 45, such as lithium alkyls such as methyllithium, butyl lithium, phenyllithium, alkali metals such as lithium, sodium or potassium, or amine bases such as, for example, potassium hexamethyldisilazide, sodium hexamethyldisilazide, lithium hexamethyldisilazide, lithium diisopropylamide, lithium diethylamide, lithium di-tert-butylamide, lithium di-adamantylamide, lithium 2,2,6,6-tetramethylethylpiperidide.
Im Rahmen einer weiteren Ausführungsform des erfindungsgemäßen Verfahrens ist es auch möglich, die gemäß Schritt a) umzusetzende Carbonsäure der Formel (II) zunächst durch Behandlung mit einer Base, bevorzugt mit etwa 0,8 bis etwa 1 ,2 mol- Äquivalenten, besonders bevorzugt mit etwa 1 mol-Äquivalent einer schwachen Base, die befähigt ist, eine Carbonsäuregruppe zu deprotonieren, in das entsprechende Car- boxylat der Formel (IV)Within the scope of a further embodiment of the process according to the invention, it is also possible for the carboxylic acid of the formula (II) to be reacted according to step a) first by treatment with a base, preferably with about 0.8 to about 1.2 mol equivalents, more preferably with about 1 molar equivalent of a weak base capable of deprotonating a carboxylic acid group into the corresponding carboxylate of the formula (IV)
zu überführen und dieses anschließend mit einer starken Base zu behandeln. Die Menge an einzusetzender starker Base wird zweckmäßig so gewählt, dass die eingesetzte Carbonsäure bzw. das intermediär gebildete Carboxylat der Formel (IV) möglichst vollständig in das Dianion, d.h. das Enolat des Carboxylats überführt wird. Vorzugsweise setzt man nach vorheriger Behandlung mit einer anderen Base etwa 0,8 bis
etwa 1 ,3 mol-Äquivalente, bevorzugt etwa 0,9 bis etwa 1 ,1 mol-Äquivalente, besonders bevorzugt 1 mol-Äquivalent der gewählten starken Base ein.and then treat this with a strong base. The amount of strong base to be used is expediently chosen so that the carboxylic acid used or the intermediate carboxylate of the formula (IV) is converted as completely as possible into the dianion, ie the enolate of the carboxylate. Preferably, after prior treatment with another base, about 0.8 to about 1.3 molar equivalents, preferably from about 0.9 to about 1.1 molar equivalents, more preferably 1 molar equivalent of the selected strong base.
Erfindungsgemäß bevorzugte starke Basen sind metallierte Dialkylamine der Formel (V)Preferred strong bases according to the invention are metallated dialkylamines of the formula (V)
MNR3R4 (V),MNR 3 R 4 (V),
wobei M Lithium, Natrium oder Kalium, bevorzugt Lithium bedeutet und die Reste R3 und R4 gleich oder verschieden sind und einen unverzweigten, verzweigten oder cycli- schen d- bis Cβ-Alkylrest oder einen Trialkylsilylrest wie beispielsweise Trimethylsilyl bedeuten. Derartige metallierte, bevorzugt lithiierte Dialkylamine sind nach dem Fachmann an sich bekannten Methoden herstellbar, beispielsweise durch Behandlung eines entsprechenden Dialkylamins, wie beispielsweise Diisopropylamin, Diisobutylamin oder Isopropyl-cyclohexylamin, mit einem geeigneten Lithiumalkyl wie beispielsweise n-where M is lithium, sodium or potassium, preferably lithium and the radicals R 3 and R 4 are identical or different and are an unbranched, branched or cyclic C 1 to C 6 alkyl radical or a trialkylsilyl radical, for example trimethylsilyl. Such metallated, preferably lithiated, dialkylamines can be prepared by methods known per se to the person skilled in the art, for example by treatment of a corresponding dialkylamine, such as, for example, diisopropylamine, diisobutylamine or isopropylcyclohexylamine, with a suitable lithium alkyl such as, for example,
Butyllithium, s-Butyllithium, tert.-Butyllithium, n-Hexyllithium, Methyllithium oder Phenyl- lithium. Derartige Verfahren sind beispielsweise in „Die Praxis des organischen Chemikers", Gattermann, Wieland neu bearbeitet von T. Wieland u. W. Sucrow , 43. Aufl., Berlin-New York, Walter de Gruyter grundlegend beschrieben. Darüber hinaus sind Lösungen derartiger Basen kommerziell verfügbar. Eine erfindungsgemäß besonders bevorzugte starke Base ist Lithium-diisoproylamin (LDA).Butyllithium, s-butyllithium, tert-butyllithium, n-hexyllithium, methyllithium or phenyl lithium. Such processes are described in detail, for example, in "The Practice of the Organic Chemist", Gattermann, Wieland, newly edited by T. Wieland and W. Sucrow, 43rd ed., Berlin-New York, Walter de Gruyter Furthermore, solutions of such bases A particularly preferred strong base according to the invention is lithium diisoproylamine (LDA).
Die Umsetzung gemäß Schritt a) der vorliegenden Erfindung wird vorteilhaft so vorgenommen, dass man eine Lösung des gewählten starken Base, vorzugsweise des ge- wählten lithiierten Dialkylamins in einem geeigneten Lösungsmittel wie beispielsweise Tetrahydrofuran, Dioxan, Dimethoxyethan, oder weitere cyclische oder acyclische Ether bereitet. Dies erfolgt üblicherweise bei Temperaturen von etwa -80°C bis etwa 0°C, bevorzugt von etwa -60°C bis etwa 0°C, besonders bevorzugt etwa -40°C bis etwa 0°C und ganz besonders bevorzugt etwa -20°C bis etwa 0°C durch Zugabe des gewählten lithiumorganischen Reagenzes zum gewählten Dialkylamin.The reaction according to step a) of the present invention is advantageously carried out by preparing a solution of the chosen strong base, preferably the chosen lithiated dialkylamine in a suitable solvent such as tetrahydrofuran, dioxane, dimethoxyethane or other cyclic or acyclic ethers. This is usually done at temperatures of about -80 ° C to about 0 ° C, preferably from about -60 ° C to about 0 ° C, more preferably about -40 ° C to about 0 ° C, and most preferably about -20 ° C to about 0 ° C by adding the selected organolithium reagent to the selected dialkylamine.
Zu der so bereiteten Lösung der starken Base wird dann üblicherweise die gewählte Ausgangsverbindung der Formel (I), gewünschtenfalls in Form einer Lösung in einem der vorstehend genannten Lösungsmittel zugegeben. Die Zugabe sowie die nachfol- gende Umsetzung der Carbonsäure der Formel (I) mit der gewählten starken Base erfolgt bevorzugt bei Temperaturen von etwa -20°C bis etwa 0°C. Nach einer Zutropf- zeit von üblicherweise etwa 10 min bis etwa 1 h ist die Bildung des Carbonsäuredi- anions üblicherweise rasch, in der Regel nach etwa 2 h, oft nach etwa 1 h abgeschlossen.To the prepared solution of the strong base is then usually added the selected starting compound of the formula (I), if desired in the form of a solution in one of the abovementioned solvents. The addition and the subsequent reaction of the carboxylic acid of the formula (I) with the selected strong base is preferably carried out at temperatures of about -20.degree. C. to about 0.degree. After a dropping time of usually about 10 minutes to about 1 hour, the formation of the carboxylic acid dione is usually rapid, usually after about 2 hours, often after about 1 hour.
Gemäß Schritt b) des erfindungsgemäßen Verfahrens setzt man das in Schritt a) erhaltene Zwischenprodukt bzw. -produktgemisch mit einer Verbindung der Formel (IM)
R2 — X (III)According to step b) of the process according to the invention, the intermediate product or product mixture obtained in step a) is reacted with a compound of the formula (III) R 2 - X (III)
um, wobei der Rest R2 die gleiche Bedeutung wie in der Zielverbindung der Formel (I) besitzt und X Chlor, Brom oder Jod, Triflat, Tosylat oder Mesylat, bevorzugt Chlor bedeutet.in which the radical R 2 has the same meaning as in the target compound of the formula (I) and X is chlorine, bromine or iodine, triflate, tosylate or mesylate, preferably chlorine.
Bei den Verbindungen der Formel (IM) handelt es sich demnach um Alkyl- oder Alke- nylhalogenide bzw. -triflate, - mesylate oder - tosylate mit bis zu 6 Kohlenstoffatomen oder um Benzylhalogenide bzw. -triflate, metylate oder tosylate, die jeweils noch weitere wie für den Rest R2 beschriebenen Substituenten aufweisen können. Erfindungsgemäß bevorzugte Verbindungen der Formel (IM) sind Allylhalogenide, insbesondere Al- lylchloride wie beispielsweise Allylchlorid, Allylbromid, 1 ,3-Dichlorpropen, 1 ,2- Dichlorpropen, 3-Chlorallylmesylat, 3-Chlorallyltriflat, 3-Chlorallyltosylat, besonders bevorzugt trans-1 ,3-Dichlorpropen.Accordingly, the compounds of the formula (III) are alkyl or alkenyl halides or triflates, mesylates or tosylates having up to 6 carbon atoms or benzyl halides or triflates, methylates or tosylates, each of which is further as described for the radical R 2 may have substituents. Preferred compounds of the formula (III) according to the invention are allyl halides, in particular allyl halides such as, for example, allyl chloride, allyl bromide, 1,3-dichloropropene, 1,2-dichloropropene, 3-chloroallyl mesylate, 3-chloroallyl triflate, 3-chloroallyl tosylate, particularly preferably trans-1 , 3-dichloropropene.
Die Umsetzung gemäß Schritt b) erfolgt vorteilhaft so, dass man zu der in Schritt a) hergestellten Lösung der doppelt deprotonierten Carbonsäure die gewählte Verbindung der Formel (IM) vorzugsweise bei einer Temperatur von etwa -20°C bis etwa 0°C zu- gibt. Dabei kann es von Vorteil sein, die gewählte Verbindung der Formel (IM) in leichtem molaren Überschuss im Hinblick auf Carbonsäuredianion bzw. die Ausgangsverbindung der Formel (M), speziell in einem molaren Verhältnis von etwa 1 zu 1 bis etwa 2 zu 1 , bevorzugt etwa 1 ,05 zu 1 bis etwa 1 ,3 zu 1 , einzusetzen. Nach Zugabe der Verbindung der Formel (IM) ist die Bildung des gewünschten Produktes der Formel (I) im vorstehend genannten Temperaturbereich üblicherweise nach etwa 1 bis etwa 24 h, oft nach etwa 3 bis etwa 6 h weitgehend abgeschlossen. Die erhaltenen Produkte bzw. Produktgemische können im Anschluss daran nach dem Fachmann bekannten Methoden aufgearbeitet, isoliert bzw. weiter aufgereinigt werden.The reaction according to step b) is advantageously carried out by adding the selected compound of the formula (III) to the solution of the double-deprotonated carboxylic acid prepared in step a) preferably at a temperature of about -20.degree. C. to about 0.degree , It may be advantageous to use the selected compound of the formula (III) in a slight molar excess with respect to the carboxylic acid dianion or the starting compound of the formula (M), especially in a molar ratio of from about 1: 1 to about 2: 1 about 1.05 to 1 to about 1.3: 1. After addition of the compound of the formula (III), the formation of the desired product of the formula (I) in the abovementioned temperature range is usually completed after about 1 to about 24 hours, often after about 3 to about 6 hours. The products or product mixtures obtained can subsequently be worked up, isolated or further purified by methods known to those skilled in the art.
Die erfindungsgemäße Umsetzung gemäß Schritt b) kann mit gutem Erfolg unter weitgehender Vermeidung von im Rahmen von Alkylierungsreaktionen üblichen Komplexbildnern bzw. Cosolventien wie beispielsweise Hexamethylphosphorsäuretriamid (HMPT), Dimethylproprylenharnstoff (DMPU), Tetramethylethylendiamin (TMEDA), Pentamethyldieethylentriamin, Kronenether z. B. 15-Krone-5, DMF, Kalium-tert-butylat durchgeführt werden. Bevorzugt führt man die Umsetzung in Gegenwart von bis zu etwa 0,25 Äquivalenten, besonders bevorzugt von bis zu 0,2 und insbesondere bevorzugt von bis zu etwa 0,1 Äquivalenten des jeweiligen Komplexbildners, bezogen auf die molare Menge an eingesetzter Base, durch. Im Rahmen einer bevorzugten Ausführungsform des erfindungsgemäßen Verfahrens führt man die Umsetzung gemäß Schritt a) und/oder Schritt b) ohne Zusatz, d.h. in Abwesenheit komplexbildender Agen- tien bzw. Cosolventien, besonders bevorzugt in Abwesenheit von HMPT durch.
Im Rahmen einer bevorzugten Ausführungsform betrifft die vorliegende Erfindung ein Verfahren zur Herstellungen von Verbindungen der Formel (Ia)The reaction according to the invention in step b) can be successfully carried out while substantially avoiding complexing agents or co-solvents such as hexamethylphosphoric triamide (HMPT), dimethylpropylene urea (DMPU), tetramethylethylenediamine (TMEDA), pentamethyldiethylenetriamine, crown ethers, for example. B. 15-crown-5, DMF, potassium tert-butoxide can be performed. The reaction is preferably carried out in the presence of up to about 0.25 equivalents, more preferably of up to 0.2 and more preferably of up to about 0.1 equivalents of the particular complexing agent, based on the molar amount of base used. Within the scope of a preferred embodiment of the process according to the invention, the reaction according to step a) and / or step b) is carried out without addition, ie in the absence of complexing agents or cosolvents, particularly preferably in the absence of HMPT. In a preferred embodiment, the present invention relates to a process for the preparation of compounds of the formula (Ia)
wobei R1' die gleichen Bedeutungen wie R1 in Formel (I) besitzen kann, bevorzugt Isopropyl bedeutet und Z Chlor, Brom oder Jod, bevorzugt Chlor bedeutet, umfassend die Schrittewherein R 1 'may have the same meanings as R 1 in formula (I), preferably isopropyl and Z is chlorine, bromine or iodine, preferably chlorine, comprising the steps
a) Umsetzung einer Verbindung der Formel (IIa)a) reaction of a compound of the formula (IIa)
R1- -0H (IIa)R1- 0H (IIa)
OO
wobei R1' die gleiche Bedeutung wie in Formel (Ia) besitzt, mit 1 ,8 bis 2,5 mol- Äquivalenten einer wie vorstehend beschriebenen Base undwherein R 1 'has the same meaning as in formula (Ia), with 1, 8 to 2.5 mol equivalents of a base as described above and
b) Umsetzung des in Schritt a) erhaltenen Zwischenproduktes mit einer Verbindung der Formel (lila)b) reaction of the intermediate obtained in step a) with a compound of the formula (IIIa)
Z^^^Z (HIa)Z ^^^ Z (HIa)
wobei Z die gleiche Bedeutung wie in Formel (Ia) besitzt und Z' gleich oder verschieden von Z sein kann und Chlor, Brom oder Jod, bevorzugt Chlor bedeutet.wherein Z has the same meaning as in formula (Ia) and Z 'may be the same or different from Z and chlorine, bromine or iodine, preferably chlorine.
Die gemäß dem erfindungsgemäßen Verfahren zugänglichen α-substituierten Carbonsäuren der Formel (I) bzw. (Ia) lassen sich ihrerseits durch dem Fachmann bekannte Methoden verestern, beispielsweise unter Säurekatalyse in Gegenwart eines Alkohols.The α-substituted carboxylic acids of the formula (I) or (Ia) obtainable by the process according to the invention can in turn be esterified by methods known to the person skilled in the art, for example by acid catalysis in the presence of an alcohol.
Darüber hinaus eignen sich die erfindungsgemäß herstellbaren Carbonsäuren auch zur Herstellung jeglicher weiterer Carbonsäurederivate wie beispielsweise Carbonsäurea- mide, -hydrazide, -azide, -Nitrile, Orthoester sowie Carbonsäurehalogenide. Derartige Derivatisierungen sind dem Fachmann bekannt und beispielsweise in Organikum, Organisch-Chemisches Grundpraktikum, 20. Auflage, Wiley-VCH Verlag Weinheim, Kapitel 7 beschrieben.In addition, the carboxylic acids which can be prepared according to the invention are also suitable for the preparation of any further carboxylic acid derivatives such as, for example, carboxylic acid amides, hydrazides, azides, nitriles, orthoesters and carboxylic acid halides. Such derivatizations are known to the person skilled in the art and are described, for example, in Organikum, Organisch-Chemisches Grundpraktikum, 20th Edition, Wiley-VCH Verlag Weinheim, Chapter 7.
Die vorliegende Erfindung betrifft daher auch ein Verfahren zur Herstellung von Carbonsäurederivaten der Formel (VI)
The present invention therefore also relates to a process for the preparation of carboxylic acid derivatives of the formula (VI)
wobeiin which
R1, R2 die in Formel (I) angegebenen Bedeutungen besitzen können undR 1 , R 2 may have the meanings given in formula (I) and
X OR5, NR6R7, Halogen, SR5 oder NHN R6R7 X OR 5 , NR 6 R 7 , halogen, SR 5 or NHN R 6 R 7
wobeiin which
R5 einen geradkettigen, verzweigten und/oder cyclischen d- bis Ci2-Alkylrest oder C7- bis C12- Aralkylrest undR 5 is a straight-chain, branched and / or cyclic C 1 - to C 12 -alkyl radical or C 7 - to C 12 -aralkyl radical and
R6, R7 unabhängig voneinander Wasserstoff oder einen geradkettigen, verzeigten und/oder cyclischen d- bis Ci2-Alkylrest oder C7- bis C12- Aralkylrest bedeuten,R 6, R 7 are independently hydrogen or a straight-chain, branched and / or cyclic d- to Ci2-alkyl or C7 to C12 aralkyl group mean
Durch Herstellung einer Carbonsäure der Formel (I) gemäß dem vorstehend beschrie- benen Verfahren und anschließender Derivatisierung.By preparing a carboxylic acid of the formula (I) according to the method described above and subsequent derivatization.
Im Rahmen einer bevorzugten Ausführungsform betrifft die vorliegende Erfindung Verfahren zur Herstellung von Carbonsäureestern der Formel (VII)In a preferred embodiment, the present invention relates to processes for the preparation of carboxylic acid esters of the formula (VII)
R1 R 1
wobeiin which
R1, R2 die in Formel (I) angegebenen Bedeutungen besitzen können undR 1 , R 2 may have the meanings given in formula (I) and
R5 einen geradkettigen, verzweigten und/oder cyclischen d- bis Ci2-Alkylrest oder C7- bis C12- Aralkylrest bedeutetR 5 represents a straight-chain, branched and / or cyclic C 1 - to C 12 -alkyl radical or C 7 - to C 12 -aralkyl radical
umfassend die Schrittecomprising the steps
i) Herstellung einer Carbonsäure der Formel (I) gemäß dem vorstehend beschriebenen Verfahren, und
ii) Veresterung der Carbonsäure der Formel (I) in Gegenwart einer Säure oder Lewis-Säure und eines Alkohols der Formel (VIII)i) preparation of a carboxylic acid of formula (I) according to the method described above, and ii) esterification of the carboxylic acid of the formula (I) in the presence of an acid or Lewis acid and an alcohol of the formula (VIII)
R5OH (VIII).R 5 OH (VIII).
Dabei bedeutet d- bis Ci2-Alkyl einen geradkettigen oder verzweigten Alkylrest mit 1 bis 12 Kohlenstoffatomen, beispielsweise wie vorstehend für d- bis Cβ-Alkyl genannt und darüber hinaus auch Heptyl, Octyl, Nonyl, Decyl, Dodecyl. Cj- bis C12- Aralkyl steht für einen über einen Alkylrest mit mindestens einem Kohlenstoffatom gebundenenIn this case, C 1 - to C 12 -alkyl denotes a straight-chain or branched alkyl radical having 1 to 12 carbon atoms, for example as mentioned above for C 1 - to C 6 -alkyl and furthermore also heptyl, octyl, nonyl, decyl, dodecyl. Cj- to C12-aralkyl is an attached via an alkyl radical having at least one carbon atom
Phenylrest, beispielsweise Benzyl, 1-Phenylethyl oder 2-Phenylethyl. Halogen bedeutet Fluor, Chlor, Brom oder Jod, bevorzugt Fluor, Chlor oder Brom. Das erfindungsgemäße Verfahren eröffnet demnach einen attraktiven Zugang zu in 2-Position substituierten Carbonsäuren und deren Ester ausgehend von den üblicherweise gut zugängli- chen unsubstituierten Carbonsäuren. Als besonderer Vorteil des erfindungsgemäßen Verfahrens ist hervorzuheben, dass es sich bei verfahrenstechnisch wie wirtschaftlich vorteilhaften Bedingungen, speziell unter Vermeidung tiefer Temperaturen sowie unter Vermeidung zusätzlicher verfahrenstechnisch wie toxikologisch problematischer Reagenzien durchführen lässt. Dabei gelingt es, die potentiell als Nebenreaktion stets auf- tretendende Selbstkondensation bei Einsatz der entsprechenden Ester bzw. Estereno- late zu vermeiden, was insbesondere bei der Synthese höher veredelter Produkte wie z.B. Pharmavorprodukten von besonderer Bedeutung ist.Phenyl, for example benzyl, 1-phenylethyl or 2-phenylethyl. Halogen is fluorine, chlorine, bromine or iodine, preferably fluorine, chlorine or bromine. Accordingly, the process according to the invention provides attractive access to carboxylic acids substituted in the 2-position and their esters starting from the usually readily accessible unsubstituted carboxylic acids. A particular advantage of the method according to the invention is that it can be carried out in procedurally and economically advantageous conditions, especially while avoiding low temperatures and while avoiding additional procedurally and toxicologically problematic reagents. In this case, it is possible to avoid the self-condensation, which always occurs as a side reaction, when the corresponding esters or ester-enolates are used, which is particularly the case in the synthesis of more highly refined products, such as e.g. Pharmavorprodukte is of particular importance.
Das folgende Beispiel dient der Veranschaulichung der Erfindung, ohne sie in irgend einer Weise zu beschränken:The following example is illustrative of the invention without in any way limiting it:
Beispiel: Herstellung von (4E)-5-chlor-2-isopropyl-4-pentensäureExample: Preparation of (4E) -5-chloro-2-isopropyl-4-pentenoic acid
In einem Kolben wurden unter Inertgasatmosphäre 28,0 g (0.28 mol) Diisopropylamin in 100 ml Tetra hydrofu ran gelöst und auf -20°C gekühlt. Anschließend wurden über 60 min hinweg 118,9 g (0,28 mol) einer 15 Gew.-%igen Lösung von n-Butyllithium in n- Hexan zugetropft. Nach Dosierende wurde 60 min bei -5°C nachgerührt. Danach wurde eine Lösung von 14,2 g (0.14 mol) 3-Methylbutansäure in 40 ml Tetra hydrofu ran innerhalb von 30 min zugetropft. Nach der vollständigen Zugabe wurde noch 15 min bei -20°C nachgerührt. Danach wurden 15,5 g (94 %-ig, 0.34 mol) trans-1 ,3-Dichlor- propen über 20 min hinweg zugetropft. Die gesamte Reaktionsmischung wurde nach der Zugabe von trans-1 ,3-Dichlorpropen noch 3 h unter langsamen Erwärmen auf Raumtemperatur nachgerührt. Danach wurde mit 250 ml 2 N Salzsäure versetzt, die Phasen getrennt und die wässrige Phase wurde zweimal mit je 200 ml Methyl-tert- butylether (MTBE) reextrahiert. Die vereinigten organischen Extrakte wurden über Natriumsulfat getrocknet und am Rotationsverdampfer eingeengt. Es wurden 21 ,5 g Rohprodukt erhalten mit einem Gehalt von 56.3 Gew.-% der gewünschten Zielverbindung. Dies entspricht einer Ausbeute von 49 %.
28.0 g (0.28 mol) of diisopropylamine were dissolved in 100 ml of tetrahydrofuran in a flask under an inert gas atmosphere and cooled to -20 ° C. Then 118.9 g (0.28 mol) of a 15 wt .-% solution of n-butyllithium in n-hexane were added dropwise over 60 minutes. After dosing 60 min at -5 ° C was stirred. Thereafter, a solution of 14.2 g (0.14 mol) of 3-methylbutanoic acid in 40 ml of tetrahydrofuran was added dropwise within 30 min. After complete addition, the mixture was stirred at -20 ° C for 15 min. Thereafter, 15.5 g (94%, 0.34 mol) of trans-1, 3-dichloro propene were added dropwise over 20 min. The entire reaction mixture was after the addition of trans-1, 3-dichloropropene stirred for 3 h under slow warming to room temperature. Thereafter, 250 ml of 2N hydrochloric acid were added, the phases were separated and the aqueous phase was reextracted twice with 200 ml of methyl tert-butyl ether (MTBE). The combined organic extracts were dried over sodium sulfate and concentrated on a rotary evaporator. There were obtained 21, 5 g of crude product with a content of 56.3 wt .-% of the desired target compound. This corresponds to a yield of 49%.
Claims
1. Verfahren zur Herstellung einer Carbonsäure der Formel (I)1. Process for the preparation of a carboxylic acid of the formula (I)
wobeiin which
R1 Wasserstoff oder unverzweigtes, verzweigtes oder cyclisches d- bis Ce- Alkyl undR 1 is hydrogen or straight-chain, branched or cyclic C 1 - to C 6 -alkyl and
R2 unverzweigtes oder verzweigtes d- bis Cβ-Alkyl oder d- bis Cβ-Alkenyl o- der Benzyl bedeutet , wobei die genannten Reste einen oder mehrere gleiche oder verschiedene Substituenten, ausgewählt aus der Gruppe der Sub- stituenten Chlor, Brom, Jod, Alkoxy, Thioalkyl, Dialkylamino, Diarylamino und Aryl aufweisen können,R 2 is unbranched or branched C 1 - to C 6 -alkyl or C 1 - to C 6 -alkenyl or of benzyl, where the radicals mentioned have one or more identical or different substituents selected from the group of the substituents chlorine, bromine, iodine, Alkoxy, thioalkyl, dialkylamino, diarylamino and aryl,
umfassend die Schrittecomprising the steps
a) Umsetzung einer Carbonsäure der Formel (II)a) reaction of a carboxylic acid of the formula (II)
Ri ^rOH (ll) R i ^ r OH (II)
OO
wobei R1 die gleiche Bedeutung wie in Formel (I) besitzt,wherein R 1 has the same meaning as in formula (I),
mit 1 ,8 bis 2,5 mol-Äquivalenten mindestens einer Base undwith 1, 8 to 2.5 molar equivalents of at least one base and
b) Umsetzung des in Schritt a) erhaltenen Produktes mit einer Verbindung derb) reacting the product obtained in step a) with a compound of
Formel (IM)Formula (IM)
R2 — X (IM)R 2 - X (IM)
wobeiin which
R2 die gleiche Bedeutung wie in Formel (I) besitzt undR 2 has the same meaning as in formula (I) and
X Chlor, Brom, Jod, Triflat, Tosylat oder Mesylat bedeutet. X represents chlorine, bromine, iodine, triflate, tosylate or mesylate.
2. Verfahren nach Anspruch 1 zur Herstellung von Verbindungen der Formel (Ia)2. Process according to Claim 1 for the preparation of compounds of the formula (Ia)
wobeiin which
R1' die gleichen Bedeutungen wie R1 in Formel (I) besitzen kann undR 1 'may have the same meanings as R 1 in formula (I) and
Z Chlor, Brom oder Jod bedeutet,Z means chlorine, bromine or iodine,
umfassend die Schrittecomprising the steps
a) Umsetzung einer Verbindung der Formel (IIa)a) reaction of a compound of the formula (IIa)
wobei R1' die gleiche Bedeutung wie in Formel (Ia) besitzt,where R 1 'has the same meaning as in formula (Ia),
mit 1 ,8 bis 2,5 mol-Äquivalenten mindestens einer Base undwith 1, 8 to 2.5 molar equivalents of at least one base and
b) Umsetzung des in Schritt a) erhaltenen Produktes mit einer Verbindung der Formel (lila)b) reaction of the product obtained in step a) with a compound of the formula (IIIa)
Z-^^^^Z' (MIa)Z - ^^^^ Z '(MIa)
wobeiin which
Z die gleiche Bedeutung wie in Formel (Ia) besitzt undZ has the same meaning as in formula (Ia) and
Z' gleich oder verschieden von Z sein kann und Chlor, Brom oder Jod bedeutet.Z 'may be the same or different from Z and is chlorine, bromine or iodine.
3. Verfahren nach Anspruch 2, dadurch gekennzeichnet, dass R1' Isopropyl bedeutet.3. The method according to claim 2, characterized in that R 1 'is isopropyl.
4. Verfahren nach Anspruch 2 oder 3, dadurch gekennzeichnet, dass Z und Z' jeweils Chlor bedeuten. 4. The method according to claim 2 or 3, characterized in that Z and Z 'are each chlorine.
5. Verfahren nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, dass man als Base eine starke Base einsetzt.5. The method according to any one of claims 1 to 4, characterized in that one uses as base a strong base.
6. Verfahren nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, dass man die Umsetzung gemäß Schritt a) so durchführt, dass man die Carbonsäure der Formel (II) zunächst durch Behandlung mit einer Base in das entsprechende Car- boxylat der Formel (IV)6. The method according to any one of claims 1 to 4, characterized in that one carries out the reaction according to step a), that the carboxylic acid of formula (II) first by treatment with a base in the corresponding carboxylate of the formula (IV )
O (IV)O (IV)
R1 R 1
OO
überführt und dieses anschließend mit einer starken Base behandelt.transferred and then treated with a strong base.
7. Verfahren nach einem der Ansprüche 1 bis 6, dadurch gekennzeichnet, dass man als starke Base ein metalliertes Dialkylamin der Formel (V)7. The method according to any one of claims 1 to 6, characterized in that the strong base is a metalated dialkylamine of the formula (V)
MNR3R4 (V),MNR 3 R 4 (V),
wobeiin which
M Lithium, Natrium oder Kalium undM lithium, sodium or potassium and
R3, R4 gleich oder verschieden sind und einen unverzweigten, verzweigten oder cyclischen d- bis Cβ-Alkylrest oder einen Trialkylsilylrest bedeuten,R 3 , R 4 are identical or different and denote an unbranched, branched or cyclic C 1 - to C 6 -alkyl radical or a trialkylsilyl radical,
einsetzt.starts.
8. Verfahren nach einem der Ansprüche 1 bis 7, dadurch gekennzeichnet, dass man als starke Base Lithium-diisoproylamid einsetzt.8. The method according to any one of claims 1 to 7, characterized in that one uses as strong base lithium diisoproylamide.
9. Verfahren nach einem der Ansprüche 1 bis 8, dadurch gekennzeichnet, dass man es bei einer Temperatur im Bereich von -20°C bis 0°C durchführt.9. The method according to any one of claims 1 to 8, characterized in that it is carried out at a temperature in the range of -20 ° C to 0 ° C.
10. Verfahren nach einem der Ansprüche 1 bis 9, dadurch gekennzeichnet, dass man Schritt a) unter Einsatz von 1 ,9 bis 2,2 mol-Äquivalenten einer starken Base durchführt.10. The method according to any one of claims 1 to 9, characterized in that one carries out step a) using 1, 9 to 2.2 mol equivalents of a strong base.
1 1. Verfahren nach einem der Ansprüche 1 bis 10, dadurch gekennzeichnet, dass man Schritt a) und/oder Schritt b) in Abwesenheit komplexierender Agentien bzw. Cosolventien durchführt. 1 1. The method according to any one of claims 1 to 10, characterized in that one carries out step a) and / or step b) in the absence of complexing agents or cosolvents.
12. Verfahren zur Herstellung von Carbonsäurederivaten der Formel (VI)12. Process for the preparation of carboxylic acid derivatives of the formula (VI)
wobeiin which
R1, R2 die in Formel (I) angegebenen Bedeutungen besitzen können undR 1 , R 2 may have the meanings given in formula (I) and
X OR5, NR6R7, Halogen, SR5 oder NHNR6R7 bedeutetX is OR 5 , NR 6 R 7 , halogen, SR 5 or NHNR 6 R 7
wobeiin which
R5 einen geradkettigen, verzweigten und/oder cyclischen d- bis C12-R 5 is a straight-chain, branched and / or cyclic C 1 to C 12
Alkylrest oder C7- bis C12- Aralkylrest undAlkyl radical or C7 to C12 aralkyl radical and
R6, R7 unabhängig voneinander Wasserstoff oder einen geradkettigen, verzeigten und/oder cyclischen d- bis Ci2-Alkylrest oder C7- bis C12- Aralkylrest bedeuten,R 6, R 7 are independently hydrogen or a linear, branched and / or cyclic d- to Ci2-alkyl or C7 to C12 aralkyl group mean
durch Herstellung einer Carbonsäure der Formel (I) gemäß dem vorstehend beschriebenen Verfahren und anschließender Derivatisierung.by preparing a carboxylic acid of the formula (I) according to the method described above and subsequent derivatization.
13. Verfahren zur Herstellung von Carbonsäureestern der Formel (VII)13. Process for the preparation of carboxylic acid esters of the formula (VII)
R1 R 1
wobeiin which
R1, R2 die in Formel (I) angegebenen Bedeutungen besitzen können undR 1 , R 2 may have the meanings given in formula (I) and
R5 einen geradkettigen, verzeigten und/oder cyclischen d- bis Ci2-Alkylrest oder C7- bis C12- Aralkylrest bedeutetR 5 represents a straight-chain, branched and / or cyclic C 1 - to C 12 -alkyl radical or C 7 - to C 12 -aralkyl radical
umfassend die Schrittecomprising the steps
i) Herstellung einer Carbonsäure der Formel (I) gemäß dem vorstehend beschriebenen Verfahren, und Veresterung der Carbonsäure der Formel (I) in Gegenwart einer Säure oder Lewis-Säure und eines Alkohols der Formel (VIII)i) preparation of a carboxylic acid of formula (I) according to the method described above, and Esterification of the carboxylic acid of the formula (I) in the presence of an acid or Lewis acid and an alcohol of the formula (VIII)
R5OH (VIII). R 5 OH (VIII).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005047450.0 | 2005-09-30 | ||
DE102005047450 | 2005-09-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007036491A1 true WO2007036491A1 (en) | 2007-04-05 |
Family
ID=37686167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/066641 WO2007036491A1 (en) | 2005-09-30 | 2006-09-22 | Method for the production of alpha-substituted carboxylic acids |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007036491A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047534A (en) * | 1990-03-26 | 1991-09-10 | Merrell Dow Pharmaceuticals Inc. | Selective adenosine receptor agents |
WO2001009079A1 (en) * | 1999-07-29 | 2001-02-08 | Speedel Pharma Ag | 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production |
-
2006
- 2006-09-22 WO PCT/EP2006/066641 patent/WO2007036491A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047534A (en) * | 1990-03-26 | 1991-09-10 | Merrell Dow Pharmaceuticals Inc. | Selective adenosine receptor agents |
WO2001009079A1 (en) * | 1999-07-29 | 2001-02-08 | Speedel Pharma Ag | 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production |
Non-Patent Citations (5)
Title |
---|
KUEHNE M E ET AL: "STUDIES IN BIOMIMETIC ALKALOID SYNTHESES 8. TOTAL SYNTHESES OF THE 14 CARBON EPIMERIC HYDROXY VINCADIFFORMINES TABERSONINE A HYDROXYMETHYL-D NORVINCADIFFORMINE AND THE 20 CARBON EPIMERIC PANDOLINES", JOURNAL OF ORGANIC CHEMISTRY, vol. 47, no. 7, 1982, pages 1335 - 1343, XP002421004, ISSN: 0022-3263 * |
MACPHEE J-A ET AL: "Steric effects in synthesis - steric limits to the alkylation of nitriles and carboxylic acids", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 36, no. 6, 1980, pages 775 - 777, XP002421050, ISSN: 0040-4020 * |
NEVALAINEN M ET AL: "Total synthesis of nor-1,6-germacradien-5-ols", JOURNAL OF ORGANIC CHEMISTRY 08 MAR 2002 UNITED STATES, vol. 67, no. 5, 8 March 2002 (2002-03-08), pages 1554 - 1560, XP002421005, ISSN: 0022-3263 * |
PADWA A ET AL: "LIGAND EFFECTS ON DIRHODIUM (II) CARBENE REACTIVITIES HIGHLY EFFECTIVE SWITCHING BETWEEN COMPETITIVE CARBENOID TRANSFORMATIONS", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, 1993, pages 8669 - 8680, XP000667320, ISSN: 0002-7863 * |
PFEFFER P E ET AL: "Alpha-Anions of Carboxylic Acids", JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, US, vol. 37, no. 3, 1972, pages 451 - 458, XP002421003, ISSN: 0022-3263 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0623575A1 (en) | Process for the preparation of ketones | |
EP1682527B1 (en) | Method for the production of statins | |
EP1197483B1 (en) | Process for the catalytic reduction of alkyne compounds | |
EP0429998B1 (en) | Process for the preparation of partially fluorinated alcohols | |
DE3917737A1 (en) | METHOD FOR PRODUCING UNSATURATED ALCOHOLS | |
DE69807700T2 (en) | PRODUCTION OF ALKALIMETAL DIARYLPHOSPHIDE AND CYCLOALKYLDIARYLPHOSPHINE | |
DE69009369T2 (en) | Process for the preparation of alkynyl compounds. | |
EP2050754A1 (en) | Method for manufacturing alkyl-methoxymethyl-trimethylsilanylmethyl amines | |
DE69520077T2 (en) | Oxotitanium complexes can be used as catalysts for asymmetric reactions, in particular for the production of beta-hydroxy-ketones or alpha-hydroxy-carboxylic acid esters | |
WO2007036491A1 (en) | Method for the production of alpha-substituted carboxylic acids | |
WO2007028714A2 (en) | Method for producing 2-substituted carboxylic acids | |
WO2011113925A2 (en) | Carbonylation of organic zinc compounds | |
DE69915430T2 (en) | Process for the preparation of halogenated phenylmalonates | |
EP0031875B1 (en) | Process for the preparation of cyclohexene derivatives | |
DE60225199T2 (en) | Process for the preparation of Michael adducts | |
DE3018575C2 (en) | Process for the preparation of an alkali metal salt of 3- (17β-hydroxyandrosten-3-one-acetal-17α-yl) -propiolic acid | |
DE69901632T2 (en) | Process for the preparation of cyclopropylacetylene derivatives | |
EP2657216B1 (en) | Method for converting farnesol to nerolidol in the presence of alpha-bisabolol | |
DE102006060949A1 (en) | Process for the preparation of menthyl derivatives | |
EP0605607B1 (en) | Preparation of manganous enolates and applications thereof | |
EP1666447B1 (en) | Process for the preparation of alpha, alpha-dialkyl, alpha-hydroxymethyl-carboxylic acid derivatives | |
DE2651085A1 (en) | NEW HYDROXIMIC ACID ESTERS AND PROCESS FOR THEIR PRODUCTION | |
DE10047111A1 (en) | Process for the preparation of DELTA · 1 · pyrrolines | |
DE2403631A1 (en) | 3-METHYL-5- (3-METHYL-3-HYDROXYBUTYL) -3CYCLOHEXENCARBOXALDEHYDE, METHOD OF ITS MANUFACTURING AND ITS USE AS A FRAGRANCE | |
WO2004094383A1 (en) | Method for the production of nicotinaldehydes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06793755 Country of ref document: EP Kind code of ref document: A1 |